Alantra continues to strengthen its leadership in the global skincare sector, having advised on four landmark transactions over the past months with a combined value of nearly $3 billion.
These transactions reflect ongoing consolidation, accelerating international expansion, and growing demand for clinically proven, science-backed innovation across the sector. Alantra’s proven ability to deliver exceptional results in highly competitive processes highlights its depth of expertise and trusted relationships with leading global investors and corporates.
Read more about what’s driving momentum in dermatology:
https://www.alantra.com/dermatology-sector-momentum/
cloud technology axon
Since Suma Capital’s entry in 2020, Gestcompost has quadrupled its E...
Capital-Riesgo.es
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Capital-Riesgo.es - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory
